# Insulin Resistance Following ADT for Prostate CA

> **NCT04658849** · EARLY_PHASE1 · WITHDRAWN · sponsor: **St. Louis University**

## Conditions studied

- Insulin Resistance
- Prostate Cancer

## Interventions

- **DRUG:** Pioglitazone 30 Mg Oral Tablet
- **DRUG:** Pioglitazone placebo tablet

## Key facts

- **NCT ID:** NCT04658849
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-02
- **Primary completion:** 2023-03-29
- **Final completion:** 2023-03-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** End of grant funding
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04658849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04658849, "Insulin Resistance Following ADT for Prostate CA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04658849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*